Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 CNS 1

Conditions

Lymphoma, Follicular 1

Interventions

Cyclophosphamide 170 Rituximab 143 Specimen Handling 82 venetoclax 79 fludarabine 79 obinutuzumab 67 Vincristine 67 Doxorubicin 65 Biopsy 64 Prednisone 63 Magnetic Resonance Spectroscopy 63 zanubrutinib 52 Lenalidomide 52 Dexamethasone 48 Cytarabine 43 Methotrexate 42 blinatumomab 40 Immunotherapy, Adoptive 38 acalabrutinib 37 Bendamustine Hydrochloride 37 Etoposide 32 fludarabine phosphate 31 ibrutinib 28 glofitamab 28 polatuzumab vedotin 26 pirtobrutinib 24 orelabrutinib 24 Gemcitabine 23 Injections 21 pembrolizumab 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × perillyl alcohol × Lymphoid × Clear all

NCT05023018 2026-03-02

NEO100 and High-Grade Meningioma

Neonc Technologies, Inc.

Phase 2 Recruiting

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡